• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

MUKOYAMA Nobuaki  向山 宣昭

ORCIDConnect your ORCID iD *help
… Alternative Names

Mukoyama Nobuaki  向山 宣昭

Less
Researcher Number 40847521
Affiliation (Current) 2025: 名古屋大学, 医学系研究科, 客員研究者
Affiliation (based on the past Project Information) *help 2020 – 2024: 名古屋大学, 医学部附属病院, 助教
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 56050:Otorhinolaryngology-related
Keywords
Principal Investigator
キメラ抗原受容体 / 樹状細胞 / 頭頸部癌 / 細胞療法 / 免疫記憶 / 抗原提示 / CAR-DC / ヘルペスウイルス / PD-1 / PD-L1 … More / 免疫チェックポイント阻害剤 / C-REV / 腫瘍免疫 / 腫瘍溶解性ウイルス Less
  • Research Projects

    (3 results)
  • Research Products

    (1 results)
  • Co-Researchers

    (5 People)
  •  新規細胞療法CAR-DCの頭頸部癌に対する抗腫瘍効果機序解析Principal Investigator

    • Principal Investigator
      向山 宣昭
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56050:Otorhinolaryngology-related
    • Research Institution
      Nagoya University
  •  Analyzing the mechanism of antitumor effects of a novel cell therapy incorporating chimeric antigen receptors into dendritic cellsPrincipal Investigator

    • Principal Investigator
      Mukoyama Nobuaki
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Nagoya University
  •  Development of a new oncolytic virus with strong immune checkpoint molecular inhibitory abilityPrincipal Investigator

    • Principal Investigator
      Mukoyama Nobuaki
    • Project Period (FY)
      2020 – 2021
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Nagoya University

All 2021

All Journal Article

  • [Journal Article] Oncolytic herpes simplex virus HF10 (canerpaturev, C-REV) promotes accumulation of CD8+PD-1- tumor-infiltrating T cells in PD-L1 enriched tumor microenvironment.2021

    • Author(s)
      Eissa I.R., Mukoyama N., Abdelmoneim, M., Naoe, Y., Matsumura, S., Bustos-Villalobos I., Ichinose T., Miyajima N., Morimoto D., Tanaka M., Fujimoto, Y., Kodera Y., Kasuya H.
    • Journal Title

      Int. J. Cancer

      Volume: 1 Issue: 1 Pages: 1-14

    • DOI

      10.1002/ijc.33550

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18H02691, KAKENHI-PROJECT-20K16438, KAKENHI-PROJECT-21H02999, KAKENHI-PROJECT-19H03434
  • 1.  西尾 直樹 (90732719)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 2.  KASUYA Hideki
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 3.  NAOE Yoshinori
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 4.  松村 繁
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 5.  一ノ瀬 亨
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi